Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma save search
BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM
Published: 2024-03-04 (Crawled : 08:00) - bridgebio.com
BBIO | $24.74 -0.84% -0.85% 2M
|
Health Technology
|
| O: 0.93%
H: 0.08%
C: -10.03%
pharma agreement
Andrew Fisher Joins Verona Pharma as General Counsel
Published: 2024-03-04 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 1.54%
H: 0.0%
C: -6.44%
pharma
Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference
Published: 2024-03-01 (Crawled : 16:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma conference health care
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 07:00) - globenewswire.com
VRNA | $15.82 -1.74% -1.83% 640K
|
Health Technology
|
| O: 3.48%
H: 2.74%
C: -3.58%
pharma year update financial results
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.29%
H: 0.08%
C: -1.17%
pharma conference health care royalty
NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: -1.16%
H: 4.01%
C: -1.38%
pharma year update financial results
Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD
Published: 2024-02-28 (Crawled : 13:30) - globenewswire.com
SILO | $1.97 0.0% 40K
|
Finance and Insurance
|
| O: 10.32%
H: 3.51%
C: -5.26%
spc-15 pharma study spc-14
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results
Published: 2024-02-28 (Crawled : 13:00) - globenewswire.com
LIFE | $1.6 -1.23% -1.25% 160K
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: -5.0%
pharma conference year financial results
Zealand Pharma convenes its Annual General Meeting 2024
Published: 2024-02-27 (Crawled : 07:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma meeting
Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
pharma year financial results
UroGen Pharma to Present at TD Cowen 44th Annual Health Care Conference
Published: 2024-02-26 (Crawled : 16:00) - biospace.com/
URGN | $13.78 -3.37% -3.48% 390K
|
Health Technology
|
| O: -0.23%
H: 5.34%
C: 5.34%
pharma conference health care
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference- Douglas A. Treco, Ph.D., CEO and Chairman, to participate in panel discussion -
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: -1.23%
H: 8.51%
C: 8.33%
pharma ceo health care
Lumos Pharma to Report Full Year 2023 Financial Results and Host Conference Call on March 7, 2024
Published: 2024-02-26 (Crawled : 14:00) - globenewswire.com
LUMO | $2.57 -1.91% -1.95% 12K
|
Health Technology
|
| O: -2.67%
H: 4.45%
C: 4.11%
pharma conference report year financial results
Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference
Published: 2024-02-26 (Crawled : 13:30) - globenewswire.com
INZY | $4.5 -1.75% -1.78% 590K
|
Health Technology
|
| O: -1.23%
H: 8.51%
C: 8.33%
pharma conference health care
NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in March
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
NAMS | $19.98 2.78% 2.7% 140K
|
n/a
|
| O: 0.22%
H: 2.16%
C: -4.87%
pharma
Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with significant improvements in fibrosis
Published: 2024-02-26 (Crawled : 07:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%
|
Health Technology
| Email alert
Add to watchlist
pharma liver disease fibrosis trial results
China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split
Published: 2024-02-23 (Crawled : 21:00) - prnewswire.com
CPHI | $0.3158 -3.63% 4.88% 440K
|
Health Technology
| Email alert
Add to watchlist
pharma china
Ocuphire Pharma to Present in the BIO CEO & Investor Conference
Published: 2024-02-23 (Crawled : 13:00) - globenewswire.com
OCUP | $1.66 -0.6% -0.6% 230K
|
Health Technology
|
| O: 0.8%
H: 0.34%
C: -0.79%
pharma ceo conference
Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates
Published: 2024-02-22 (Crawled : 21:00) - globenewswire.com
ATHA | $2.12 2.91% 2.83% 200K
|
Health Technology
|
| O: 1.78%
H: 1.0%
C: -1.75%
pharma business year pipeline financial results
Poolbeg Pharma PLC Announces Director/PDMR Shareholding
Published: 2024-02-22 (Crawled : 10:00) - biospace.com/
AMYT | $14.7 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.